Vitamin D metabolism, cartilage and bone fracture repair

Molecular and Cellular Endocrinology

Volumn 347, Issue 1-2, 2011, Pages 48-54

  St Arnaud, René ^a,b   Naja, Roy Pascal ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

1,25 Dihydroxyvitamin D; 24,25 Dihydroxyvitamin D; Chondrocytes; Cyp24a1; Cyp27b1; Vitamin D receptor

Indexed keywords

24,25 DIHYDROXYVITAMIN D; CALCITRIOL; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE ASSOCIATED 3 RECEPTOR; UNCLASSIFIED DRUG;

BONE CELL; BONE DEVELOPMENT; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CARTILAGE CELL; CELL MATURATION; CELLULAR DISTRIBUTION; CYP24A1 GENE; CYP27B1 GENE; FRACTURE HEALING; GENE EXPRESSION; GENE LOCATION; GROWTH PLATE; HORMONE ACTION; HUMAN; MARKER GENE; METABOLITE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION; VDR GENE; VITAMIN D METABOLISM;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CARTILAGE; CHONDROCYTES; FRACTURE HEALING; FRACTURES, BONE; HUMANS; MICE; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 82455167905     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.018     Document Type: Review

References (91)

1. Al-Aqeel A., Ozand P., Sobki S., Sewairi W., Marx S. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII). Clin. Endocrinol. 1993, 39:229-237.
2. Amling M., Priemel M., Holzmann T., Chapin K., Rueger J.M., Baron R., Demay M.B. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140:4982-4987.
3. Aronson J. Experimental and clinical experience with distraction osteogenesis. Cleft Palate Craniofac. J. 1994, 31:473-481. (discussion 481-482).
4. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 1990, 30:109-116.
5. Balsan S., Garabedian M., Larchet M., Gorski A.M., Cournot G., Tau C., Bourdeau A., Silve C., Ricour C. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1, 25-dihydroxyvitamin D. J. Clin. Invest. 1986, 77:1661-1667.
6. Baran D.T. Nongenomic actions of the steroid hormone 1 alpha, 25-dihydroxyvitamin D3. J. Cell Biochem. 1994, 56:303-306.
7. Boivin G., Mesguich P., Pike J.W., Bouillon R., Meunier P.J., Haussler M.R., Dubois P.M., Morel G. Ultrastructural immunocytochemical localization of endogenous 1, 25- dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. Bone Miner. 1987, 3:125-136.
8. 3. Vitamin D 2005, 575-597. Elsevier, Academic Press, San Diego. second ed. D. Feldman (Ed.).
9. Boyan B.D., Schwartz Z., Carnes D.L., Ramirez V. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology 1988, 122:2851-2860.
10. Boyan B.D., Sylvia V.L., Dean D.D., Del Toro F., Schwartz Z. Differential regulation of growth plate chondrocytes by 1alpha, 25-(OH)2D3 and 24R, 25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit. Rev. Oral Biol. Med. 2002, 13:143-154.
11. Boyan B.D., Sylvia V.L., McKinney N., Schwartz Z. Membrane actions of vitamin D metabolites 1alpha, 25(OH)2D3 and 24R, 25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice. J. Cell Biochem. 2003, 90:1207-1223.
12. Boyan B.D., Jennings E.G., Wang L., Schwartz Z. Mechanisms regulating differential activation of membrane-mediated signaling by 1alpha, 25(OH)2D3 and 24R, 25(OH)2D3. J. Steroid Biochem. Mol. Biol. 2004, 89-90:309-315.
13. Boyan B.D., Wong K.L., Wang L., Yao H., Guldberg R.E., Drab M., Jo H., Schwartz Z. Regulation of growth plate chondrocytes by 1, 25-dihydroxyvitamin D3 requires caveolae and caveolin-1. J. Bone Miner. Res. 2006, 21:1637-1647.
14. Boyan B.D., Hurst-Kennedy J., Denison T.A., Schwartz Z. 24R, 25-dihydroxyvitamin D3 [24R, 25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha, 25(OH)2D3 in hypertrophic cells. J. Steroid Biochem. Mol. Biol. 2010, 121:212-216.
15. Canadillas S., Rodriguez-Benot A., Rodriguez M. More on the bone-kidney axis - lessons from hypophosphataemia. Nephrol. Dial Transplant. 2007, 22:1521-1523.
16. Chen J., Olivares-Navarrete R., Wang Y., Herman T.R., Boyan B.D., Schwartz Z. Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1, 25-dihydroxyvitamin D3 in osteoblasts. J. Biol. Chem. 2010, 285:37041-37050.
17. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D.W. De-orphanization of Cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 2003, 278:38084-38093.
18. Christakos S., Dhawan P., Liu Y., Peng X., Porta A. New insights into the mechanisms of vitamin D action. J Cell Biochem. 2003, 88:695-705.
19. Cianferotti L., Cox M., Skorija K., Demay M.B. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc. Natl. Acad. Sci. USA 2007, 104:9428-9433.
20. Colnot C., Thompson Z., Miclau T., Werb Z., Helms J.A. Altered fracture repair in the absence of MMP9. Development 2003, 130:4123-4133.
21. Dardenne O., Prud'homme J., Hacking S.A., Glorieux F.H., St-Arnaud R. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone 2003, 32:332-340.
22. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689S-1696S.
23. Denison T.A., Koch C.F., Shapiro I.M., Schwartz Z., Boyan B.D. Inorganic phosphate modulates responsiveness to 24, 25(OH)2D3 in chondrogenic ATDC5 cells. J. Cell Biochem. 2009, 107:155-162.
24. Donohue M.M., Demay M.B. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 2002, 143:3691-3694.
25. Ferguson C., Alpern E., Miclau T., Helms J.A. Does adult fracture repair recapitulate embryonic skeletal formation?. Mech. Dev. 1999, 87:57-66.
26. Hadjiargyrou M., Lombardo F., Zhao S., Ahrens W., Joo J., Ahn H., Jurman M., White D.W., Rubin C.T. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J. Biol. Chem. 2002, 277:30177-30182.
27. Halloran B.P., DeLuca H.F. Effect of vitamin D deficiency on skeletal development during early growth in the rat. Arch. Biochem. Biophys. 1981, 209:7-14.
28. Harrison J.R., Petersen D.N., Lichtler A.C., Mador A.T., Rowe D.W., Kream B.E. 1, 25-dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma line ROS 17/2.8. Endocrinology 1989, 125:327-333.
29. Hatano H., Siegel H.J., Yamagiwa H., Bronk J.T., Turner R.T., Bolander M.E., Sarkar G. Identification of estrogen-regulated genes during fracture healing, using DNA microarray. J. Bone Miner. Metab. 2004, 22:224-235.
30. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner Res. 1998, 13:325-349.
31. Helm S., Sylvia V.L., Harmon T., Dean D.D., Boyan B.D., Schwartz Z. 24, 25-(OH)2D3 regulates protein kinase C through two distinct phospholipid-dependent mechanisms. J. Cell Physiol. 1996, 169:509-521.
32. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., Petruschke R.A., Chen E., de Papp A.E. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J. Clin. Endocrinol. Metab. 2005, 90:3215-3224.
33. Hurst-Kennedy J., Boyan B.D., Schwartz Z. Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes. Biochim. Biophys. Acta 2009, 1793:836-846.
34. Hurst-Kennedy J., Zhong M., Gupta V., Boyan B.D., Schwartz Z. 24R, 25-Dihydroxyvitamin D3, lysophosphatidic acid, and p53: a signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis. J. Steroid Biochem. Mol. Biol. 2010, 122:264-271.
35. Johnson J.A., Grande J.P., Roche P.C., Kumar R. Ontogeny of the 1, 25-dihydroxyvitamin D3 receptor in fetal rat bone. J. Bone Miner. Res. 1996, 11:56-61.
36. Kato A., Seo E.G., Einhorn T.A., Bishop J.E., Norman A.W. Studies on 24R, 25-dihydroxyvitamin D3: evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus. Bone 1998, 23:141-146.
37. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94:9831-9835.
38. Li Y.C., Amling M., Pirro A.E., Priemel M., Meuse J., Baron R., Delling G., Demay M.B. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998, 139:4391-4396.
39. Liu S., Gupta A., Quarles L.D. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr. Opin. Nephrol. Hypertens. 2007, 16:329-335.
40. Makin G., Lohnes D., Byford V., Ray R., Jones G. Target cell metabolism of 1, 25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem. J. 1989, 262:173-180.
41. Masuda S., Byford V., Arabian A., Sakai Y., Demay M.B., St-Arnaud R., Jones G. Altered pharmacokinetics of 1alpha, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 2005, 146:825-834.
42. Masuyama R., Stockmans I., Torrekens S., Van Looveren R., Maes C., Carmeliet P., Bouillon R., Carmeliet G. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J. Clin. Invest. 2006, 116:3150-3159.
43. Naja R.P., Dardenne O., Arabian A., St Arnaud R. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1, 25-dihydroxyvitamin D3 in growth plate development. Endocrinology 2009, 150:4024-4032.
44. Nakazawa T., Nakajima A., Seki N., Okawa A., Kato M., Moriya H., Amizuka N., Einhorn T.A., Yamazaki M. Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J. Orthop. Res. 2004, 22:520-525.
45. Narbaitz R., Stumpf W.E., Sar M., Huang S., DeLuca H.F. Autoradiographic localization of target cells for 1 alpha, 25- dihydroxyvitamin D3 in bones from fetal rats. Calcif. Tissue Int. 1983, 35:177-182.
46. Nemere I., Farach-Carson M.C., Rohe B., Sterling T.M., Norman A.W., Boyan B.D., Safford S.E. Ribozyme knockdown functionally links a 1, 25(OH)2D3 membrane binding protein (1, 25D3-MARRS) and phosphate uptake in intestinal cells. Proc. Natl. Acad. Sci. USA 2004, 101:7392-7397.
47. Nemere I., Garbi N., Hammerling G.J., Khanal R.C. Intestinal cell calcium uptake and the targeted knockout of the 1, 25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57. J. Biol. Chem. 2010, 285:31859-31866.
48. Noda M., Vogel R.L., Craig A.M., Prahl J., DeLuca H.F., Denhardt D.T. Identification of a DNA sequence responsible for binding of the 1, 25-dihydroxyvitamin D3 receptor and 1, 25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 1990, 87:9995-9999.
49. Norman A.W. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006, 147:5542-5548.
50. Ohyama Y., Yamasaki T. Eight cytochrome P450s catalyze vitamin D metabolism. Front. Biosci. 2004, 9:3007-3018.
51. Omdahl J.L., Bobrovnikova E.A., Choe S., Dwivedi P.P., May B.K. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 2001, 66:381-389.
52. Portale A.A., Halloran B.P., Morris R.C. Physiologic regulation of the serum concentration of 1, 25-dihydroxyvitamin D by phosphorus in normal men. J. Clin. Invest. 1989, 83:1494-1499.
53. Raval-Pandya M., Porta A.R., Christakos S. Mechanism of action of 1,25-dihydroxyvitamin D3 on intestinal calcium absorption and renal calcium transport. Vitamin D: Physiology, Molecular Biology, and Clinical Applications 1998, 163-173. Humana Press Inc., Totowa, NJ. M.F. Holick (Ed.).
54. Rucker D., Allan J.A., Fick G.H., Hanley D.A. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002, 166:1517-1524.
55. Rundle C.H., Wang H., Yu H., Chadwick R.B., Davis E.I., Wergedal J.E., Lau K.H., Mohan S., Ryaby J.T., Baylink D.J. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 2006, 38:521-529.
56. Sabbagh Y., Carpenter T.O., Demay M.B. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc. Natl. Acad. Sci. USA 2005, 102:9637-9642.
57. Saito H., Kusano K., Kinosaki M., Ito H., Hirata M., Segawa H., Miyamoto K., Fukushima N. Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha, 25-dihydroxyvitamin D3 production. J. Biol. Chem. 2003, 278:2206-2211.
58. Sakai Y., Kishimoto J., Demay M.B. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J. Clin. Invest. 2001, 107:961-966.
59. Schwartz Z., Boyan B. The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro. Endocrinology 1988, 122:2191-2198.
60. Schwartz Z., Schlader D.L., Ramirez V., Kennedy M.B., Boyan B.D. Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro. J. Bone Miner. Res. 1989, 4:199-207.
61. Schwartz Z., Swain L.D., Ramirez V., Boyan B.D. Regulation of arachidonic acid turnover by 1, 25-(OH)2D3 and 24, 25- (OH)2D3 in growth zone and resting zone chondrocyte cultures. Biochim. Biophys. Acta 1990, 1027:278-286.
62. Schwartz Z., Dennis R., Bonewald L., Swain L., Gomez R., Boyan B.D. Differential regulation of prostaglandin E2 synthesis and phospholipase A2 activity by 1, 25-(OH)2D3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63). Bone 1992, 13:51-58.
63. Schwartz Z., Dean D., Walton J., Brooks B., Boyan B. Treatment of resting zone chondrocytes with 24, 25-dihydroxyvitamin D3 [24, 25-(OH)2D3] induces differentiation into a 1, 25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes. Endocrinology 1995, 136:402-411.
64. Schwartz Z., Gilley R.M., Sylvia V.L., Dean D.D., Boyan B.D. Prostaglandins mediate the effects of 1, 25-(OH)2D3 and 24, 25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner. Bone 1999, 24:475-484.
65. Schwartz Z., Sylvia V.L., Luna M.H., DeVeau P., Whetstone R., Dean D.D., Boyan B.D. The effect of 24R, 25-(OH)(2)D(3) on protein kinase C activity in chondrocytes is mediated by phospholipase D whereas the effect of 1alpha, 25-(OH)(2)D(3) is mediated by phospholipase C. Steroids 2001, 66:683-694.
66. Schwartz Z., Shaked D., Hardin R.R., Gruwell S., Dean D.D., Sylvia V.L., Boyan B.D. 1alpha, 25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-beta activity via phospholipase A2-dependent production of lysophospholipid. Steroids 2003, 68:423-437.
67. Schwartz Z., Graham E.J., Wang L., Lossdorfer S., Gay I., Johnson-Pais T.L., Carnes D.L., Sylvia V.L., Boyan B.D. Phospholipase A2 activating protein (PLAA) is required for 1alpha, 25(OH)2D3 signaling in growth plate chondrocytes. J. Cell Physiol. 2005, 203:54-70.
68. Seo E.G., Norman A.W. Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24, 25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J. Bone Miner. Res. 1997, 12:598-606.
69. Seo E.G., Kato A., Norman A.W. Evidence for a 24R, 25(OH)2-vitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Biochem. Biophys. Res. Commun. 1996, 225:203-208.
70. Seo E.G., Einhorn T.A., Norman A.W. 24R, 25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 1997, 138:3864-3872.
71. Shaul P.W., Anderson R.G. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 1998, 275:L843-L851.
72. Skorija K., Cox M., Sisk J.M., Dowd D.R., MacDonald P.N., Thompson C.C., Demay M.B. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol. Endocrinol. 2005, 19:855-862.
73. Song Y., Peng X., Porta A., Takanaga H., Peng J.B., Hediger M.A., Fleet J.C., Christakos S. Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1, 25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 2003, 144:3885-3894.
74. St-Arnaud R. Mutant mouse models of vitamin D metabolic enzymes. Vitamin D 2005, 105-116. Elsevier Academic Press, San Diego. second ed. D. Feldman (Ed.).
75. St-Arnaud R., Arabian A., Travers R., Barletta F., Raval-Pandya M., Chapin K., Depovere J., Mathieu C., Christakos S., Demay M.B., Glorieux F.H. Deficient mineralization of intramembranous bone in vitamin D-24- hydroxylase-ablated mice is due to elevated 1, 25-dihydroxyvitamin D and not to the absence of 24, 25-dihydroxyvitamin D. Endocrinology 2000, 141:2658-2666.
76. Swain L.D., Schwartz Z., Caulfield K., Brooks B.P., Boyan B.D. Nongenomic regulation of chondrocyte membrane fluidity by 1, 25-(OH)2D3 and 24, 25-(OH)2D3 is dependent on cell maturation. Bone 1993, 14:609-617.
77. Sylvia V.L., Schwartz Z., Del Toro F., DeVeau P., Whetstone R., Hardin R.R., Dean D.D., Boyan B.D. Regulation of phospholipase D (PLD) in growth plate chondrocytes by 24R, 25-(OH)2D3 is dependent on cell maturation state (resting zone cells) and is specific to the PLD2 isoform. Biochim. Biophys. Acta 2001, 1499:209-221.
78. Takamoto M., Tsuji K., Yamashita T., Sasaki H., Yano T., Taketani Y., Komori T., Nifuji A., Noda M. Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-kappaB ligand (RANKL) gene expression in chondrocytes. J. Endocrinol. 2003, 177:413-421.
79. Tay B.K., Le A.X., Gould S.E., Helms J.A. Histochemical and molecular analyses of distraction osteogenesis in a mouse model. J. Orthop. Res. 1998, 16:636-642.
80. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., Vamvakas E.C., Dick I.M., Prince R.L., Finkelstein J.S. Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 1998, 338:777-783.
81. Thompson Z., Miclau T., Hu D., Helms J.A. A model for intramembranous ossification during fracture healing. J. Orthop. Res. 2002, 20:1091-1098.
82. Underwood J.L., DeLuca H.F. Vitamin D is not directly necessary for bone growth and mineralization. Am. J. Physiol. 1984, 246:E493-E498.
83. Van Cromphaut S.J., Dewerchin M., Hoenderop J.G., Stockmans I., Van Herck E., Kato S., Bindels R.J., Collen D., Carmeliet P., Bouillon R., Carmeliet G. Duodenal calcium absorption in vitamin D receptor-knockout mice. functional and molecular aspects. Proc. Natl. Acad. Sci. USA 2001, 98:13324-13329.
84. van Deurs B., Roepstorff K., Hommelgaard A.M., Sandvig K. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 2003, 13:92-100.
85. Wali R.K., Kong J., Sitrin M.D., Bissonnette M., Li Y.C. Vitamin D receptor is not required for the rapid actions of 1, 25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. J. Cell Biochem. 2003, 88:794-801.
86. Wang Y., Chen J., Lee C.S., Nizkorodov A., Riemenschneider K., Martin D., Hyzy S., Schwartz Z., Boyan B.D. Disruption of Pdia3 gene results in bone abnormality and affects 1alpha, 25-dihydroxy-vitamin D3-induced rapid activation of PKC. J. Steroid Biochem. Mol. Biol. 2010, 121:257-260.
87. Wasserman R.H., Smith C.A., Brindak M.E., De Talamoni N., Fullmer C.S., Penniston J.T., Kumar R. Vitamin D and mineral deficiencies increase the plasma membrane calcium pump of chicken intestine. Gastroenterology 1992, 102:886-894.
88. Weinstein R.S., Underwood J.L., Hutson M.S., DeLuca H.F. Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus. Am. J. Physiol. 1984, 246:E499-E506.
89. Wientroub S., Fisher L., Reddi A., Termine J. Noncollagenous bone protiens in experimental rickets in the rat. Mol. Cell Biochem. 1987, 74:157-162.
90. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
91. Zanello L.P., Norman A.W. Electrical responses to 1alpha, 25(OH)2-Vitamin D3 and their physiological significance in osteoblasts. Steroids 2004, 69:561-565.